Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor.
Kim YP, Park D, Kim JJ, Chi WJ, Lee SH, Lee SY, Kim S, Chung JM, Jeon J, Lee BD, Shin JH, Lee YI, Cho H, Lee JM, Kang HC.
Kim YP, et al. Among authors: lee sh, lee sy, lee yi, lee jm, lee bd.
PLoS One. 2014 Dec 1;9(12):e113442. doi: 10.1371/journal.pone.0113442. eCollection 2014.
PLoS One. 2014.
PMID: 25438047
Free PMC article.